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Introduction 
Venous Thromboembolism (VTE) encom-
passes both Deep Vein Thrombosis (DVT) 
and Pulmonary Embolism (PE) (Welch, 
2010). Accounting for the death of 5-10% of 
hospital inpatients, PE is the most common 
avertible cause of inpatient death (Cohen, 
Tapson, Bergmann, Goldhaber, Kakkar, De-
slandes, Huang, Zayaruzny, Emery & Ander-
son, 2008).  
Virchow’s triad as explained in Delaune, Nan-
da & Barker (2008) defines the three contrib-
uting factors associated with VTE formation. 
These factors are venous stasis which is re-
duced or stagnant blood flow in deep veins, 
venous injury which causes the release of 
procoagulant factors within the bloodstream 
as part of the normal clotting mechanism and 
hypercoagulability which refers to a more in-
trinsically active clotting state, often as a re-
sult of traumatic injury (Maclean, 2014). 
The quoted incidence of DVT in the neurosur- 
gical setting varies from 9-50% (Delaune et  
al., 2008), with patients suffering from multi-
system traumatic injuries in addition to their 
neurotrauma, being at the greatest risk (Reiff, 
Haricharan, Bullington, Griffin, McGwin & 
Rue, 2009). Despite the high prevalence and 
associated morbidity of VTE development, 
thromboprophylaxis in the neurosurgical set-
ting remains a source of contention due to 
concerns of iatrogenic haemorrhage progres-
sion associated with anticoagulant thrombo-
prophylaxis. There is further reticence to use 
early chemical VTE prophylaxis due to the 
absence of a national care standard and the 
nature of previous studies which are by ma-
jority, limited to retrospective and observa-
tional studies (Phelan, 2012). 
Method 
A literature search was conducted utilising 
the electronic databases CINAHL, PubMed 
and MEDLINE in August 2014 using the key-
words venous thromboembolism, thrombo-
prophylaxis, neurosurgical, head trauma, 
enoxaparin and intracranial bleeding. Articles 
were limited to English papers, which were 
published from 2008 to present. The refer-
ence lists of articles were searched for addi-
tional publications. A total of 30 papers were 
reviewed and 15 included in the review com-
bining both contemporary literature and semi-
nal work pieces. 
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Review of the literature 
VTE is a common complication for hospital-
ised patients irrespective of their pathology, 
and no group of patients has a higher risk 
than those who have suffered traumatic injury 
(Urden, Stacy & Lough, 2015). Taniguchi, Fu-
kuda, Daitoku, Minakawa, Odagiri, Suzuki, 
Fukui, Asano & Ohkuma (2009), conducted a 
prospective study of 37 patients stratified into 
risk categories which analysed the prevalence 
of venous thromboembolism in the neurosur-
gical setting. Their study group received 
thromboprophylaxis with graded compression 
stockings, with or without the use of intermit-
tent pneumatic compression (IPC), but did not 
receive chemical prophylaxis. Their results 
suggested that mechanical prophylaxis alone 
was inadequate with the prevalence of DVT 
within their cohort at 13.5% which is within the 
expected baseline of risk in the untreated. Al-
so of note, within their study group, of those 
found to have DVTs, there was a 60% preva-
lence of PEs requiring long term treatment. 
Similarly, Phelan (2012), conducted a critical 
literature review of 56 papers to determine the 
safety and efficacy of chemical VTE prophy-
laxis in the setting of neurosurgical patients. 
They reported rates of DVTs in patients who 
had suffered traumatic brain injury (TBI) in the 
intensive care unit (ICU) setting as being as 
high as 51%, with a subsequent post throm-
botic-syndrome rate of 30%; a syndrome, it 
should be noted, associated with a poorer ex-
pected long term outcome than chronic fibrotic 
lung disease and diabetes. They advised that 
initiation of low molecular weight heparin 
(LMWH) prophylaxis was critical once haem-
orrhage progression was deemed stable, sug-
gesting 48 hours postop to be the optimal 
time, due to the increasing requirement of in-
vasive prophylaxis via use of devices such as 
inferior vena cava (IVC) filters beyond this 
period. Scudday, Brasel, Webb, Codner, Som-
berg, Weigelt, Herrmann & Peppard (2011), 
also hypothesised that the use of anticoagu-
lant prophylaxis would decrease the incidence 
of VTE without increasing intracranial haemor-
rhage in their retrospective case control study 
of 812 patients. Anticoagulant prophylaxis in 
the form of unfractionated heparin (UFH) or 
LMWH was initiated in 402 (49.5%) patients. 
169 commenced anticoagulant prophylaxis 
within 48 hours of presentation, whilst 242 
patients had treatment initiated within 72 
hours. Findings of the study indicated that pa-
tients receiving anticoagulant prophylaxis in 
contrast to mechanical prophylaxis had a re-
duced VTE incidence of 1% and 3% respec-
tively. 
Opinions of ideal time to initiate chemical 
prophylaxis for VTE within the neurosurgical 
community vary between clinicians. It is nev-
ertheless rarely disputed that timely and ap-
propriate prophylaxis of VTE reduces morbidi-
ty. A study of Canadian practice conducted by 
Scales, Riva-Cambrin, Le, Pinto, Cook & 
Granton (2009), surveyed 160 neurosurgeons 
and intensivists, confirming that the majority of 
clinicians utilised anticoagulant prophylaxis in 
the neurosurgical setting despite the per-
ceived risks of haemorrhagic progression. 
88% of surveyed intensivists and 75% of sur-
veyed neurosurgeons described the use of 
UFH, LMWH or other anticoagulant thrombo-
prophylaxis for patients with diffuse axonal 
injury after severe traumatic brain injury. The 
majority (58%) who favoured anticoagulant 
thromboprophylaxis reported that they would 
initiate anticoagulant thromboprophylaxis with-
in two days of injury. In the instance of pa-
tients suffering intracranial haemorrhage after 
severe traumatic brain injury, 60% of those 
surveyed reported that they would initiate anti-
coagulant thromboprophylaxis during the inpa-
tient course. In this case however, the initia-
tion time was more varied with 34% of those 
surveyed stating that they would commence 
anticoagulant prophylaxis within two days of 
surgery, 57% would commence within four 
days and 80% within one week. The use of 
anticoagulant thromboprophylaxis in patients 
who are considered high risk for the develop-
ment of VTE undergoing intracranial neurosur-
gery is also supported by Barillari & Pasca 
(2009) who state that the use of IPC in addi-
tion to low dose UFH or LMWH post-
operatively is more efficient than the use of 
IPC alone. This statement is based on their 
review of guidelines presented from the Amer-
ican College of Chest Physicians (2008), con-
sensus conference on antithrombotic therapy. 
In spite of the observed efficacy of anticoagu-
lant thromboprophylaxis, a clinical decision 
analysis study conducted by Scales, Riva-
Cambrin, Wells, Athaide, Granton & Detsky 
(2010), revealed that the probability of no in-
tracranial haemorrhage progression in the 
context of mechanical or anticoagulant throm-
boprophylaxis was associated with expected 
values of 0.90 (90%) and 0.89 (89%) respec-
tively, meaning that the decision to anticoagu-
late patients was approximately equivocal in 
terms of its absolute risk. It went on however 
to conclude that given the implications of intra-
cranial haemorrhage when measured against 
the implications of VTE, that the risks while 
equivalent numerically, were not necessarily 
contextually equal.  
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In favour of early anticoagulation, it has been 
shown that delayed time to treatment with ap-
propriate anticoagulation therapy has been 
shown to have a significantly increased bur-
den of disease. Reiff et al (2009) conducted a 
retrospective, multicentre study which includ-
ed 15,269 eligible patients of which 2000 had 
sustained traumatic brain injury (TBI) investi-
gating DVT risk dependent on admission time 
to commencement of prophylaxis. They found 
that patients suffering from TBI are associated 
with a high risk of DVT which became signifi-
cantly greater when the presentation time to 
anticoagulant prophylaxis was longer. In their 
observed cohort when the time to commence 
prophylaxis was beyond 48 hours, DVT risk in 
TBI surged to 15.4%, compared with a signifi-
cantly less risk of 3.6% in TBI patients who 
had prophylaxis initiated at 0-24 hours. In con-
tradiction to their findings, the retrospective 
study by Salottolo, Offner, Levy, Mains, Slone 
& Bar-Or (2010), was not able to establish an 
association between the development of VTE 
and the timing of anticoagulant prophylaxis 
commencement. 
Reticence to initiate anticoagulation is based 
on the perceived risk of haemorrhagic pro-
gression. However, some evidence suggests 
that intracranial haemorrhage rates within 
those treated with anticoagulant prophylaxis 
are significantly less than is intuitively as-
sumed. In a retrospective study undertaken at 
an academic tertiary care facility including 
4293 patients undergoing surgery for intracra-
nial brain tumour, Chaichana, Pendleton, 
Jackson, Martinez-Gutierrez, Diaz-Stransky, 
Aguayo, Olivi, Weingart, Gallia, Lim, Brem & 
Quinones-Hinojosa (2013), reviewed 126 pa-
tients who acquired DVT and/or PE; 67% suf-
fered solely DVT, 25% PE and 8% both. All 
were diagnosed within 30 days of surgery 
through a variety of means including ultra-
sound, CT pulmonary angiogram and ventila-
tion perfusion scan. The majority of patients 
diagnosed with VTE (81 patients, 64%) were 
treated with UFH, and in follow up imaging 
only 5 (4%) had an intracranial haemorrhage. 
While the cohort studied was not focused 
purely on patients suffering TBI, given the de-
gree of parenchymal injury associated with 
tumour and other surgery, a degree of extrap-
olation is not unreasonable. Similarly, Dudley, 
Aziz, Bonnici, Saluja, Lamourex, Kalmovitch, 
Gurasahaney, Razez, Maleki & Marcoux 
(2010), undertook a retrospective study that 
reviewed 694 cases of moderate to severe 
traumatic brain injury over a period of 5 years 
and analysed the use of LMWH for VTE 
prophylaxis. Eligible patients, 287 in total, 
were fitted with mechanical prophylaxis; both 
graded compression stockings and IPC, and 
were also commenced on LMWH at 48-72 
hours post traumatic injury. It is important to 
note that in this instance, patients were com-
menced on LMWH only when two or more CT 
scans displayed intracranial haemorrhage. 
186 patients underwent a CT scan within 
three weeks of commencing LMWH and only 
one (0.4%) developed progression of a known 
intracranial haemorrhage. The authors con-
cluded that early LMWH commencement post 
traumatic brain injury showed a decreased 
incidence of VTE (7.3%) and should be con-
sidered safe given that only 0.4% suffered a 
progression of intracranial haemorrhage. 
Farooqui, Hiser, Barnes & Litofsky (2013), 
concluded that the use of anticoagulant 
prophylaxis in head injured patients appears 
to be effective in preventing DVT and PE with-
out increase in haemorrhage rates in their ret-
rospective study of 236 patients. They re-
viewed an anticoagulant VTE prophylaxis pro-
tocol after TBI mandating the use of anticoag-
ulant prophylaxis (UFH or LMWH) at 24 hours 
post injury for all patients. The analysis com-
pared two groups of patients; one cohort of 
107 patients treated without this protocol and 
the other cohort of 129 patients were in the 
described manner. The incidence of PE in the 
former was 3.74%, and 0.78% in the latter. 
Curiously, without the protocol, the observed 
number of haemorrhagic progressions, (3 inci-
dences) was higher than those treated with 
the protocol (1 incident). Similarly, Minshall, 
Eriksson, Leon, Doben, McKinzie & Fakhry 
(2011), retrospectively reviewed the charts of 
386 patients admitted to an ICU with a hospi-
tal stay of greater than 48 hours with signifi-
cant TBI over a 42 month period. Their aim 
was to compare the use of LMWH and UFH to 
better gauge haemorrhage progression risk in 
patients suffering severe traumatic brain injury 
and to explore the related rates of VTE. Of 
their study group; 158 patients were treated 
with LMWH, 171 were treated with UFH and 
57 patients had sequential compression devic-
es, the latter considered the control group. 
The observed incidence of VTE within the 
treated groups of patients was 0.9% and 1.9% 
respectively. Patients in the untreated group 
had a 47% mortality rate in stark contrast to 
the observed 5% in the LMWH group and 
16% in the UFH group. In patients treated with 
UFH the incidence of DVT was 1% and 3.7% 
for PE, only marginally higher than those pa-
tients treated with LMWH. After the com-
mencement of treatment, only 8 (5%) patients 
in the LMWH group and 20 patients (12%) in 
the UFH group had a progression of their in-
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tracranial haemorrhage which, as with the 
study by Farooqui et al., (2013), is considera-
bly lower than their control group with a pro-
gression rate of 25%. Again, early initiation of 
anticoagulant prophylaxis in patients with se-
vere TBI was shown to significantly reduce the 
risk of VTE without significant risk of intracra-
nial haemorrhage progression. Depew, Hu, 
Nguyen & Driessen (2008), suggested early 
prophylaxis had merit following conducting a 
retrospective study including 124 patients who 
suffered blunt head trauma reviewed rates of 
ICH progression with early prophylaxis. 62 
patients were commenced on LMWH, 20 pa-
tients on UFH and 42 patients had pneumatic 
compression devices alone. Of those with 
chemical VTE prophylaxis, 10 developed VTE 
and 3 developed ICH progression of which 
only one was significant. In contrast, a deci-
sion analysis study conducted by Niemi & 
Armstrong (2010) proposed that if bleeding 
risk was high intraoperatively, the administra-
tion of anticoagulant prophylaxis should be 
postponed until as late as possible, but conse-
quences should be considered case depend-
ent. They concluded that patients considered 
very high risk from thrombus development 
should have anticoagulant prophylaxis imple-
mented provided risk of inadequate prevention 
outweighed the risk of bleeding. 
Nursing Considerations 
The essential role of the neuroscience nurse 
is continually evolving. Neuroscience nurses 
are conscientiously accountable for the coor-
dination of patient care throughout recovery 
and are instrumental in the prevention of VTE 
in the neurosurgical setting. Prevention of 
VTE and risk reduction should be considered 
fundamental nursing goals (Andrews & Ha-
bashi, 2010). Rapid patient assessment in 
order to review effectiveness of care, quick 
identification of issues and prompt manage-
ment of complications is essential in high risk 
patients. Due to their close affiliation to the 
patient, the nurse is often the first to observe 
the clinical signs associated with VTE and is 
responsible for implementing prevention strat-
egies and treatment for those who develop 
DVT or PE. DVT, as described in Scruth & 
Haynes (2014), typically presents with pain in 
the calf, often with redness, swelling and dis-
tended superficial veins. The affected calf is 
often warmer to touch and Homan’s sign, pain 
in the calf on dorsiflexion of the foot, may also 
be present. Although a late sign of DVT, cya-
notic discolouration due to deoxygenated hae-
moglobin present within the stagnant veins, 
may also be present (Söhne, Vink & Büller, 
2009). As explained in Hix & Tamburri (2009), 
the signs and symptoms of PE include dysp-
noea, tachypnoea, inspirational chest pain, 
chest wall tenderness, decreased spO2, 
cough, cyanosis, tachycardia, fever and 
haemoptysis. PE may present with varied 
signs and this can often make the diagnosis 
challenging (Mathers, 2015). A possible PE 
should be considered in any patient who dis-
plays or reports new onset of cardiorespiratory 
signs and symptoms or any risk factors for 
VTE (Hix & Tamburri, 2009).  
The neuroscience nurse is also responsible 
for providing sufficient patient education for 
patients considered high risk or who have de-
veloped DVT or PE. In the context of ICU pa-
tients, Andrews & Habashi (2010), recom-
mend the use of minimal sedation where pos-
sible to promote activity including ventilator 
management and weaning as early as possi-
ble and the implementation and continuation 
of prophylaxis for the prevention of VTE.  
It is extremely important that the neuroscience 
nurse be attuned to the potential for patients 
to precipitously deteriorate in the setting of 
anticoagulant prophylaxis, particularly given 
the inability to immediately reverse the effects 
of anticoagulants such as, LMWH, given that 
an exclusive antidote is not available (Niemi & 
Armstrong, 2010). 
Conclusion 
VTE thromboprophylaxis in the neurosurgical 
setting remains controversial and can be chal-
lenging and complex. As highlighted in the 
review, the consequences of VTE can be dev-
astating and patients with neurotrauma are 
amongst those at greatest risk. Complicating 
that which would otherwise be a simple mat-
ter, the risk of haemorrhagic progression and 
the consequences of postoperative bleeding 
lend credence to a more conservative ap-
proach, with delays to onset of chemical 
prophylaxis being the most commonly de-
scribed intervention. As a nurse within the 
neurosurgical field, the key challenges remain 
early detection of VTE complications within 
the untreated cohort of patients, and the early 
detection of haemorrhage within the treated 
population.  
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